Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|
| Total revenue | 67.11%2.32B | 1.28B | 0 | 181.53%1.39B | 492.41M |
| Cost of revenue | 268.83%2.1B | 1.32B | 0 | 323.63%569.94M | 134.54M |
| Gross profit | -73.72%214.52M | -44.2M | 0 | 128.11%816.34M | 357.88M |
| Operating expense | 25.74%3.28B | 1.86B | 0 | -43.81%2.61B | 4.65B |
| Operating profit | -70.95%-3.07B | -1.9B | 0 | 58.15%-1.8B | -4.29B |
| Net non-operating interest income (expenses) | -437.30%-312.03M | -208.11M | 0 | -203.34%-58.07M | -19.15M |
| Non-operating interest income | 1,108.47%713K | --689K | --0 | -32.18%59K | --87K |
| Non-operating interest expense | 384.69%259.57M | --175.69M | --0 | 54,545.92%53.55M | --98K |
| Total other finance cost | 1,061.07%53.18M | --33.11M | --0 | -76.06%4.58M | --19.13M |
| Net investment income | 0 | 3.01M | |||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||
| Income from associates and other participating interests | |||||
| Special income (charges) | -98.11%8.46M | 8.45M | 0 | 123.15%446.22M | -1.93B |
| Less:Impairment of capital assets | ---- | ---- | ---- | ---- | --626.52M |
| Less:Other special charges | 98.11%-8.46M | ---8.45M | --0 | -146.97%-446.22M | --950.05M |
| Less:Write off | ---- | ---- | ---- | ---- | --350.87M |
| Other non-operating income (expenses) | -118.77%-212.71M | -210.2M | 0 | -188.98%-97.23M | -33.65M |
| Income before tax | -138.30%-3.59B | -2.32B | 0 | 75.99%-1.51B | -6.27B |
| Income tax | -58.18%6.46M | 1.94M | 0 | 278.00%15.45M | 4.09M |
| Net income | -136.31%-3.59B | -2.33B | 0 | 75.76%-1.52B | -6.27B |
| Net income continuous operations | -136.31%-3.59B | ---2.33B | --0 | 75.76%-1.52B | ---6.27B |
| Noncontrolling interests | |||||
| Net income attributable to the company | -136.31%-3.59B | -2.33B | 0 | 75.76%-1.52B | -6.27B |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -136.31%-3.59B | -2.33B | 0 | 75.76%-1.52B | -6.27B |
| Gross dividend payment | |||||
| Basic earnings per share | -107.66%-42.78 | -21.4889 | 0 | 74.25%-20.6011 | -80.0064 |
| Diluted earnings per share | -107.66%-42.78 | -21.4889 | 0 | 74.25%-20.6011 | -80.0064 |
| Dividend per share | |||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |